Market Access Consulting - McKesson Canada
What Strategic Market Access Offers
PDCI Market Access offers highly strategic market access advice and services which support biopharmaceutical manufacturers to achieve timely and optimal pricing and reimbursement for their medicines. This includes:
Preparing for Market Access
Understanding the Canadian regulatory pricing, commercial, and market access environments.
Forecasting the disease landscape, place in therapy and anticipated commercial opportunity.
Interpreting the value proposition from the perspective of organizations that influence access (e.g., health technology assessment organizations, and formulary decision makers).
Anticipating the market access pathway and stakeholder perspectives to leverage opportunities and mitigate challenges.
Understanding the Canadian regulatory pricing, commercial, and market access environments.
Forecasting the disease landscape, place in therapy and anticipated commercial opportunity.
Interpreting the value proposition from the perspective of organizations that influence access (e.g., health technology assessment organizations, and formulary decision makers).
Anticipating the market access pathway and stakeholder perspectives to leverage opportunities and mitigate challenges.
Identifying options and developing customized strategies, recommendations, and roadmaps to achieve optimal market access.
Employing quantitative and qualitative research methods to analyze and achieve a deep understanding in all of the above.
Implementing Market Access Strategies
Developing strategic pricing, health technology assessment, and payer dossiers, which involve thoughtful clinical positioning, and sophisticated health economic modelling, reporting, and indirect treatment comparison capabilities.
Supporting clients with strategic advice throughout the health technology assessment and payer negotiation processes to attain optimal funding/reimbursement for new medicines in Canada.
Developing strategic pricing, health technology assessment, and payer dossiers, which involve thoughtful clinical positioning, and sophisticated health economic modelling, reporting, and indirect treatment comparison capabilities.
Supporting clients with strategic advice throughout the health technology assessment and payer negotiation processes to attain optimal funding/reimbursement for new medicines in Canada.
With the diversified and extensive expertise of our team, PDCI delivers high-quality, customized and reliable market access advice and services to ensure Canadian patients achieve timely and optimal access to new medicines. For more information about PDCI’s services, please visit www.pdci.ca